BellRing Brands, Inc. (BRBR) - 10-Q Summary
Business Context and Reporting Period
This summary covers the quarterly period ended June 30, 2026 (Fiscal Q3 2026). BellRing Brands, Inc. is a consumer products holding company operating in the global proactive wellness category, primarily known for its Premier Protein and Dymatize brands. The company operates as a single reporting segment.
Key Financial Metrics
| Metric | Q3 2026 | Q3 2025 | 9M 2026 | 9M 2025 |
|---|---|---|---|---|
| Net Sales | $570.4M | $547.5M | $1,706.4M | $1,668.4M |
| Gross Profit | $163.3M | $193.6M | $485.8M | $583.0M |
| Gross Margin | 28.6% | 35.4% | 28.5% | 35.0% |
| Operating Profit | $65.4M | $44.8M | $209.9M | $255.2M |
| Net Earnings | $34.2M | $21.0M | $111.8M | $156.6M |
| Diluted EPS | $0.29 | $0.16 | $0.95 | $1.21 |
| Operating Cash Flow (9M) | $65.0M (vs. $91.5M prior year) | |||
| Long-Term Debt | $1,135.3M (Principal: $1,140.0M) | |||
| Cash & Equivalents | $50.4M |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 4% in Q3 and 2% for the nine months ended June 30, 2026. Dymatize sales grew 27% in Q3 driven by price increases and volume, while Premier Protein sales grew 1% on volume gains offset by lower net selling prices due to promotions.
- Profitability: Operating profit increased 46% in Q3 primarily due to a $68.1M legal provision in the prior year period that did not recur. However, for the nine-month period, operating profit declined 18% due to higher net product costs ($94.3M increase) and increased advertising expenses ($12.7M increase).
- Cost Pressures: Gross margins compressed significantly due to higher raw material, manufacturing, and freight costs. Specific charges included a $10.0M finished products inventory reserve and an $11.3M charge for a third-party ingredient quality issue.
- Share Repurchases: The company repurchased 4.86 million shares for $134.5M during the nine months ended June 30, 2026, at an average price of $27.41 per share.
Guidance, Outlook, and Risks
- Legal Settlements: The company reached settlements regarding the "Joint Juice" litigation. A $2.0M payment was made, with an additional $17.2M due by August 10, 2026, for the New York case. A separate Multistate Settlement requires an additional $68.8M payment by August 10, 2026. Total estimated liability for these matters was $86.0M as of June 30, 2026.
- Securities Litigation: A putative securities class action and a consolidated shareholder derivative action were filed in early 2026 alleging misstatements regarding financial performance. The company is unable to estimate potential losses at this early stage.
- Market Risks: Management cites inflationary pressures on input costs, tariffs, and global trade policies as key risks. A military conflict in the Middle East has disrupted energy markets, though management does not currently expect a material adverse effect.
- Liquidity: The company maintains a $500M Revolving Credit Facility with $197.6M available as of June 30, 2026. It remains in compliance with its debt covenants, including a maximum net leverage ratio of 6.00:1.00.
Investor Verification Checklist
- Settlement Payments: Verify the timing and impact of the upcoming $86.0M total legal settlement payments due in August 2026 on cash flow.
- Margin Recovery: Monitor whether pricing actions and cost optimization initiatives can offset persistent inflation in raw materials and freight to stabilize gross margins.
- Inventory Levels: Review the significant increase in inventory ($480.6M vs. $330.4M prior year) and the specific charges taken for inventory reserves and quality issues.
- Debt Servicing: Assess the impact of higher interest rates on the variable portion of the Revolving Credit Facility and the fixed 7.00% Senior Notes maturing in 2030.
- Legal Uncertainty: Track the status of the pending securities class action and derivative suits, as outcomes could result in unforeseen liabilities.